The intricate interface between immune and metabolic regulation: A role for leptin in the pathogenesis of multiple sclerosis?

Journal of Leukocyte Biology

Volumn 84, Issue 4, 2008, Pages 893-899

  Matarese, Giuseppe ^a   Procaccini, Claudio ^a   De Rosa, Veronica ^a  

^a CNR   (Italy)

Author keywords

Autoimmunity; Multiple sclerosis; Th1; Treg

Indexed keywords

LEPTIN; TRANSCRIPTION FACTOR IIIA;

ADIPOCYTE; ALLERGIC ENCEPHALOMYELITIS; ANOREXIA NERVOSA; AUTOIMMUNE DISEASE; BODY MASS; CD4+ T LYMPHOCYTE; CONFERENCE PAPER; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE MODEL; HORMONE RELEASE; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFECTION SENSITIVITY; INFLAMMATORY INFILTRATE; INNATE IMMUNITY; MALNUTRITION; METABOLIC REGULATION; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; WILD TYPE;

ANIMALS; AUTOIMMUNE DISEASES; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HOMEOSTASIS; HUMANS; IMMUNITY; INFLAMMATION; LEPTIN; METABOLISM; MULTIPLE SCLEROSIS; OBESITY; T-LYMPHOCYTES, REGULATORY;

ANIMALIA; MUS;

EID: 54249102288     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0108022     Document Type: Conference Paper

References (59)

1. Samartin, S., Chandra, R. (2001) Obesity, overnutrition and the immune system. Nutr. Res. 21, 240-243.
2. Friedman, J. M., Halaas, J. L. (1998) Leptin and the regulation of body weight in mammals. Nature 395, 763-770.
3. Matarese, G., La Cava, A., Sanna, V., Lord, G. M., Lechler, R. I., Fontana, S., Zappacosta, S. (2002) Balancing susceptibility to infection and autoimmunity: a role for leptin? Trends Immunol. 23, 182-187.
4. Chehab, F. F., Lim, M., Lu, R. (1996) Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat. Genet. 12, 318-320.
5. Bennett, B. D., Solar, G. P., Yuan, J. Q., Mathias, J., Thomas, G. R., Matthews, W. (1996) A role for leptin and its cognate receptor in hematopoiesis. Curr. Biol. 6, 1170-1180.
6. Sierra-Honigmann, M. R., Nath, A. K., Murakami, C., García- Cardeña, G., Papapetropoulos, A., Sessa, W. C., Madge, L. A., Schechner, J. S., Schwabb, M. B., Polverini, P. J., Flores-Riveros, J. R. (1998) Biological action of leptin as an angiogenic factor. Science 281, 1683-1686.
7. Ducy, P., Amling, M., Takeda, S., Priemel, M., Schilling, A. F., Beil, F. T., Shen, J., Vinson, C., Rueger, J. M., Karsenty, G. (2000) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100, 197-207.
8. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., Friedman, J. M. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432.
9. Landman, R. E., Puder, J. J., Xiao, E., Freda, P. U., Ferin, M., Wardlaw, S. L. (2003) Endotoxin stimulates leptin in the human and nonhuman primate. J. Clin. Endocrinol. Metab. 88, 1285-1291.
10. Orbak, Z., Ertekin, V., Akay, F., Ozkan, B., Ors, R. (2003) Serum leptin levels in neonatal septicemia. J. Pediatr. Endocrinol. Metab. 16, 727-731.
11. Bornstein, S. R., Preas, H. L., Chrousos, G. P., Suffredini, A. F. (1998) Circulating leptin levels during acute experimental endotoxiemia and antiinflammatory therapy in humans. J. Infect. Dis. 178, 887-890.
12. Koç, E., Ustündaǧ, G., Aliefendioǧlu, D., Ergenekon, E., Bideci, A., Atalay, Y. (2003) Serum leptin levels and their relationship to tumor necrosis factor-α and interleukin-6 in neonatal sepsis. J. Pediatr. Endocrinol. Metab. 16, 1283-1287.
13. Yarasheski, K. E., Zachwieja, J. J., Horgan, M. M., Powderly, W. G., Santiago, J. V., Landt, M. (1997) Serum leptin concentrations in human immunodeficiency virus-infected men with low adiposity. Metabolism 46, 303-305.
14. Zhang, F., Basinski, M. B., Beals, J. M., Briggs, S. L., Churgay, L. M., Clawson, D. K., DiMarchi, R. D., Furman, T. C., Hale, J. E., Hsiung, H. M., Schoner, B. E., Smith, D. P., Zhang, X. Y., Wery, J. P., Schevitz, R. W. (1997) Crystal structure of the obese protein leptin-E100. Nature 387, 206-209.
15. Tartaglia, L. A., Dembski, M., Weng, X., Deng, N., Culpepper, J., Devos, R., Richards, G. J., Campfield, L. A., Clark, F. T., Deeds, J., Muir, C., Sanker, S., Moriarty, A., Moore, K. J., Smutko, J. S., Mays, G. G., Wool, E. A., Monroe, C. A., Tepper, R. I. (1995) Identification and expression cloning of a leptin receptor, Ob-R. Cell 83, 1263-1270.
16. Tartaglia, L. A. (1997) The leptin receptor. J. Biol. Chem. 272, 6093-6100.
17. Park, H. Y., Kwon, H. M., Lim, H. J., Hong, B. K., Lee, J. Y., Park, B. E., Jang, Y., Cho, S. Y., Kim, H. S. (2001) Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp. Mol. Med. 33, 95-102.
18. Lord, G. M., Matarese, G., Howard, J. K., Baker, R. J., Bloom, S. R., Lechler, R. I. (1998) Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394, 897-901.
19. Sánchez-Margalet, V., Martín-Romero, C., Santos-Alvarez, J., Goberna, R., Najib, S., Gonzalez-Yanes, C. (2003) Role of leptin as an immunomodulator of blood mononuclear cells: mechanisms of action. Clin. Exp. Immunol. 133, 11-19.
20. Banks, A. S., Davis, S. M., Bates, S. H., Myers, M. G. (2000) Activation of downstream signals by the long form of the leptin receptor. J. Biol. Chem. 275, 14563-14572.
21. Bjørbaek, C., Buchholz, R. M., Davis, S. M., Bates, S. H., Pierroz, D. D., Gu, H., Neel, B. G., Myers Jr., M. G., Flier, J. S. (2001) Divergent roles of SHP-2 in ERK activation by leptin receptors. J. Biol. Chem. 276, 4747-4755.
22. Sweeney, G. (2002) Leptin signaling. Cell. Signal. 14, 655-663.
23. Martin-Romero, C., Sanchez-Margalet, V. (2001) Human leptin activates PI3K and MAPK pathways in human peripheral blood mononuclear cells: possible role of Sam68. Cell. Immunol. 212, 83-91.
24. van den Brink, G. R., O'Toole, T., Hardwick, J. C., van den Boogaardt, D. E., Versteeg, H. H., van Deventer, S. J., Peppelenbosch, M. P. (2000) Leptin signaling in human peripheral blood mononuclear cells, activation of p38 and p42/44 mitogen-activated protein (MAP) kinase and p70 S6 kinase. Mol. Cell Biol. Res. Commun. 4, 144-150.
25. Ozata, M., Ozdemir, I. C., Licinio, J. (1999) Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin mediated defects. J. Clin. Endocrinol. Metab. 84, 3686-3695.
26. Farooqi, I. S., Matarese, G., Lord, G. M., Keogh, J. M., Lawrence, E., Agwu, C., Sanna, V., Jebb, S. A., Perna, F., Fontana, S., Lechler, R. I., DePaoli, A. M., O'Rahilly, S. (2002) Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J. Clin. Invest. 110, 1093-1103.
27. Howard, J. K., Lord, G. M., Matarese, G., Vendetti, S., Ghatei, M. A., Ritter, M. A., Lechler, R. I., Bloom, S. R. (1999) Leptin protects mice from starvation induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J. Clin. Invest. 104, 1051-1059.
28. Lord, G. M., Matarese, G., Howard, J. K., Lechler, R. I. (2001) The bioenergetics of the immune system. Science 292, 855-856.
29. Frauwirth, K. A., Riley, J. L., Harris, M. H., Parry, R. V., Rathmell, J. C., Plas, D. R., Elstrom, R. L., June, C. H., Thompson, C. B. (2002) The CD28 signaling pathway regulates glucose metabolism. Immunity 16, 769-777.
30. Khaled, A. R., Durum, S. K. (2002) Lymphocide: cytokines and the control of lymphoid homeostasis. Nat. Rev. Immunol. 2, 817-830.
31. La Cava, A., Matarese, G. (2004) The weight of leptin in immunity. Nat. Rev. Immunol. 4, 371-379.
32. Caldefie-Chezet, F., Poulin, A., Tridon, A., Sion, B., Vasson, M. P. (2001) Leptin: a potential regulator of polymorphonuclear neutrophil bactericidal action? J. Leukoc. Biol. 69, 414-418.
33. Caldefie-Chezet, F., Poulin, A., Vasson, M. P. (2003) Leptin regulates functional capacities of polymorphonuclear neutrophils. Free Radic. Res. 37, 809-814.
34. Siegmund, B., Lear-Kaul, K. C., Faggioni, R., Fantuzzi, G. (2002) Leptin deficiency, not obesity, protects mice from Con A-induced hepatitis. Eur. J. Immunol. 32, 552-560.
35. Zhao, Y., Sun, R., You, L., Gao, C., Tian, Z. (2003) Expression of leptin receptors and response to leptin stimulation of human natural killer cell lines. Biochem. Biophys. Res. Commun. 300, 247-252.
36. Tian, Z., Sun, R., Wei, H., Gao, B. (2002) Impaired natural killer (NK) cell activity in leptin receptor deficient mice: leptin as a critical regulator in NK cell development and activation. Biochem. Biophys. Res. Commun. 298, 297-302.
37. Dixit, V. D., Mielenz, M., Taub, D. D., Parvizi, N. (2003) Leptin induces growth hormone secretion from peripheral blood mononuclear cells via a protein kinase C- and nitric oxide-dependent mechanism. Endocrinology 144, 5595-5603.
38. Williams, K. C., Ulvestad, E., Hickey, W. F. (1994) Immunology of multiple sclerosis. Clin. Neurosci. 2, 229-245.
39. Matarese, G., Di Giacomo, A., Sanna, V., Lord, G. M., Howard, J. K., Di Tuoro, A., Bloom, S. R., Lechler, R. I., Zappacosta, S., Fontana, S. (2001) Requirement for leptin in the induction and progression of autoimmune encephalomyelitis. J. Immunol. 166, 5909-5916.
40. Sanna, V., Di Giacomo, A., La Cava, A., Lechler, R. I., Fontana, S., Zappacosta, S., Matarese, G. (2003) Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J. Clin. Invest. 111, 241-250.
41. De Rosa, V., Procaccini, C., La Cava, A., Chieffi, P., Nicoletti, G. F., Fontana, S., Zappacosta, S., Matarese, G. (2006) Leptin neutralization interferes with pathogenic T cell autoreactivity in autoimmune encephalomyelitis. J. Clin. Invest. 116, 447-455.
42. Matarese, G., Carrieri, P. B., La Cava, A., Perna, F., De Rosa, V., Aufiero, D., Fontana, S., Zappacosta, S. (2005) Leptin increase in multiple sclerosis associates with reduced number of CD4+CD25+ regulatory T cells. Proc. Natl. Acad. Sci. USA 102, 5150-5155.
43. Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., Klonowski, P., Austin, A., Lad, N., Kaminski, N., Galli, S. J., Oksenberg, J. R., Raine, C. S., Heller, R., Steinman, L. (2002) Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8, 500-508.
44. Batocchi, A. P., Rotondi, M., Caggiula, M., Frisullo, G., Odoardi, F., Nociti, V., Carella, C., Tonali, P. A., Mirabella, M. (2003) Leptin as a marker of multiple sclerosis activity in patients treated with interferon-β. J. Neuroimmunol. 139, 150-154.
45. Tilg, H., Moschen, A. R. (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 6, 772-783.
46. Dixit, V. D., Yang, H., Sun, Y., Weeraratna, A. T., Youm, Y. H., Smith, R. G., Taub, D. D. (2007) Ghrelin promotes thymopoiesis during aging. J. Clin. Invest. 117, 2778-2790.
47. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., Toda, M. (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164.
48. Fisson, S., Darrasse-Jèze, G., Litvinova, E., Septier, F., Klatzmann, D., Liblau, R., Salomon, B. L. (2003) Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J. Exp. Med. 198, 737-746.
49. Fontenot, J. D., Gavin, M. A., Rudensky, A. Y. (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330-336.
50. Gavin, M. A., Clarke, S. R., Negrou, E., Gallegos, A., Rudensky, A. (2002) Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat. Immunol. 3, 33-41.
51. Klein, L., Khazaie, K., von Boehmer, H. (2003) In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. USA 100, 8886-8891.
52. Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S. A., Wilkinson, J. E., Galas, D., Ziegler, S. F., Ramsdell, F. (2001) Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27, 68-73.
53. Chatila, T. A., Blaeser, F., Ho, N., Lederman, H. M., Voulgaropoulos, C., Helms, C., Bowcock, A. M. (2000) JM2, encoding a fork head-related protein, is mutated in X linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest. 106, R75-R81.
54. Sakaguchi, S. (2005) Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6, 345-352.
55. De Rosa, V., Procaccini, C., Calì, G., Pirozzi, G., Fontana, S., Zappacosta, S., La Cava, A., Matarese, G. (2007) A key role of leptin in the control of regulatory T cell proliferation. Immunity 26, 241-255.
56. Heilbronn, L. K., Campbell, L. V. (2008) Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Curr. Pharm. Des. 14, 1225-1230.
57. Amar, S., Zhou, Q., Shaik-Dasthagirisaheb, Y., Leeman, S. (2007) Diet-induced obesity in mice causes changes in immune responses and bone loss manifested by bacterial challenge. Proc. Natl. Acad. Sci. USA 104, 20466-20471.
58. Giesser, B., Beres-Jones, J., Budovitch, A., Herlihy, E., Harkema, S. (2007) Locomotor training using body weight support on a treadmill improves mobility in persons with multiple sclerosis: a pilot study. Mult. Scler. 13, 224-231.
59. Fontana, L., Eagon, J. C., Trujillo, M. E., Scherer, P. E., Klein, S. (2007) Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 56, 1010-1013.